Acute Renal Failure
System inflammatory response syndrome and sepsis for surgery patients
System inflammatory response syndrome (SIRS) -
Sepsis — SIRS + septic site
• Systemic Inflammatory Response Syndrome Criteria (ACCP/SCCM Consensus)
– Temperature >38°C or <36°
– Heart rate >90 bpm
– Respiratory Rate>20 or PaCO2<32mmHg
– WBC>12,000/μl or <4,000/μl
• Sepsis: 2 or more-
– Tachycardia >90bpm
– Rectal temp>38°C or <36°C
– Tachypnea(>20bpm)
• With 1 or more
– Alteration in mental status
– Hypoxemia (PaO2<72mmHG at FiO20.21)
– Elevated plasma lactate
– Oligouria
Sepsis classification by ethiology:-
• Gram (+)
• Gram (-)
• Aerobic
• Anaerobic
• Mycobacterial
• Staphylococcus
• Streptococcus
• Mixt-sepsis
Sepsis classification by primary focus:-
• Post-traumatic:
– burn
– wound
• Lung
• Angiogenic
• Cardiogenic
• Abdominal:
– Biliary
– Pancreatic
– Intestinal
– Peritoneal
– Appendicular
• Soft-tissue inglammation
• Urological etc
Sepsis classification by development with a time (stages):-
• Toxemia
• Septicemia
• Septicopyemia
Sepsis classification by clinical course:-
• Fulminant or the acutest
• Acute
• Chronic
Sepsis classification by clinical severity:-
Sepsis
Severe sepsis – sepsis + organ dysfunction
Septic shock – sepsis + hypotension
(Multiple organ dysfunction)
• Severe Sepsis
– Tachycardia >90bpm
– Rectal temp>38°C or <36°C
– Tachypnea(>20bpm) or PaCO2<32mmHg
– Hypotension despite fluid resuscitation
– Presence of perfusion abnormalities: lactic acidosis, oligouria, alteration in mental status
• Mediators of Sepsis
– Lipospolysaccharide (gram-negative bacteria)
– Lipoteichoic acid (gram-positive bacteria
– Peptidoglycan
– Cytokines
• IL-1 – mediates systemic effects of infection
• IL-6 – effects liver function
• TNF-α- potentiates the activation of neutrophils and macrophages
• IL-8 – regulates neutrophil function, mediates lung injury in sepsis
– Complement
– Nitric Oxide
– Lipid Mediators: Chemotaxis, Cell activation, Vascular Permeability
Phospholipase A2
PAF
Eicosanoids
– Adhesion Molecules
• Selectins
• Leukocyte Antigens
• Circulatory Manifestations
– Vasodilation
– Tachycardia
– Increased Cardiac Output
– Depressed Myocardial Function
– Increased Delivery
– Decreased Extraction
– Downregulation of catecholamine receptors
– Increased local vasodilating substances
• Nitric oxide
• Prostacyclin
• Decreased Oxygen
• Low pH
• Increased anaerobic metabolism
• Shunting
• Pulmonary Dysfunction
– Endothelial Injury
– Interstitial Edema
– Alveolar Edema
– Neutrophil entrapment
– Injury Type I pneumocyte
– Hyperplasia Type II pneumocyte
– Continued Neutrophil, monocyte, leukocyte and platelet aggregation
– GI
• Ileus
• Malabsorption
• Overgrowth of bacteria, Translocation
– Liver
– Renal
– CNS
• Organisms
– Lower Respiratory Tract Infections (25%)
– Urinary Tract Infections (25%)
– Gastrointestinal Infections (25%)
– Soft Tissue Infections (15%)
– Reproductive Organs (5%)
• Risk Factors
– Extremes of Age (<10 and >70 years)
– Pre-existing Organ Dysfunction
– Immunosuppression
– Major Surgery, Trauma, Burns
– Indwelling Devices
– Prolonged Hospitalization
– Malnutrition
– Prior Antibiotic Treatment
• Principles for Management of Sepsis
– Early Recognition
– Early and Adequate Antibiotic Therapy
– Source Control
– Early Hemodynamic Resuscitation and continued support
– Drotrecogin Alpha (Apache II>25)
– Tight Glycemic Control
– Ventilatory Support
• Drotrecogin-alpha/Recombinant Human Activated Protein C
– Reduced levels of anti-inflammatory mediators
– Activated Protein C
• Inhibits thrombosis
• Decreases inflammation
• Promotes fibrinolysis
– Side Effect: Bleeding
– PROWESS study group
• Lower mortality rate (24.7 vs. 30.8%)
• Steroids???
– Older trials used high doses
– Recent trials suggest low dose, with taper and tight glycemic control may improve outcome
– Vasopressor-dependent shock
– Cosyntropin Stim Test-Relative Adrenal Insufficiency (<9mcg/dL)
• Experimental Therapies
– Dopexamine- beta 2 adrenergic and dopaminergic effects, NO alpha adrenergic activity
– Vasopressin- reduces inducible NO synthase, upregulates endogenous catecholamine receptors
– Phosphodiesterase Inhibitors-ionotropic agents with vasodilating actions
– Nitric Oxide Inhibitors- N-monomethyl-l-arginine
ARDS :-
• Frequent Complication in Sepsis(40%)
• Adult Respiratory Distress Syndrome
– Oxygenation abnormality: PaO2/FiO2 ratio less than 200
– Bilateral opacities on CXR
– PAOP <18mm Hg or no evidence of L atrial hypertension
• Frequent Complication in Sepsis(40%)
• Adult Respiratory Distress Syndrome
– Oxygenation abnormality: PaO2/FiO2 ratio less than 200
– Bilateral opacities on CXR
– PAOP <18mm Hg or no evidence of L atrial hypertension
– Frequency of ARDS in sepsis 18-38%
– 16% patients die w/irreversible respiratory failure
• Pathophysiology
– Injury to Alveolocapillary unit
– Exudative Phase
• Endothelial injury, immune cell infiltration, pneumocyte and endothelial injury and necrosis
– Proliferative Phase
• Organization of exudate, myofibroblast proliferation
• Conversion of exudate to fibrous tissue
– Fibrotic Phase
• Remodeling of fibrosis, microcystic honeycomb formation and traction bronchiectasis
• Management
– Lung-Protective Strategy-Reduction of Barotrauma
– TV 5ml/kg
– Longer inspiratory time
– Peak Inspiratory Pressure<35-40cmH2O
– Permissive Hypercapnea
– PEEP
Acute Renal Failure
• Increases Mortality in ICU 30%
• Physiology
– Glomerular Filtration dependent on perfusion pressure (MAP 60-80mmHg)
– Less than 60mmHG
• Decreased flow
• Arterial dilation in pre-glomerular arterioles (prostaglandins)
• Constriction of post-glomerular arterioles (angiotensin II)
• As Renal Perfusion Falls
– Increased reabsorption in proximal tubules
• 90% water is reabsorbed (normal is 60%)
– Decreased fluid to the distal tubules
• Loss of potassium elimination
– Tubular cells dependent on aerobic respiration
• Ascending loop is most sensitive to ischemia
Date: 2015-12-11; view: 896
|